A recent study suggests that individuals who stop using popular GLP-1 drugs like Mounjaro or Wegovy tend to recover reduced body mass much more quickly than those who stop traditional diet and exercise plans.
Research printed in a leading health publication demonstrates that while obese individuals often shed about a fifth of their body weight while on the medication, the weight returns at an average rate of 0.8 kg per month once they quit.
"Individuals using such medications need to be aware of the danger of rapid weight regain when the treatment concludes," warns researcher Dr. Susan Jebb.
This pace of regain suggests a return to starting weight in about one and a half years.
Comparing Approaches
The study, which looked at dozens of studies involving thousands of participants, contrasted the effects of these new drugs with older methods.
Scientists note that individuals who lose weight through lifestyle changes alone usually have a less rapid creep back—perhaps 100 grams monthly—post-intervention.
Understanding the Fast Regain
Nutrition scientists believe the mode of action of the jabs explains the accelerated rebound.
GLP-1 drugs imitate a body's own chemical called GLP-1, which helps regulate appetite.
"Sustained high doses of GLP-1 concentrations far above than the body's typical production could lead to the body to generate a reduced amount of its endogenous hormone, and may also lessen responsiveness to its actions," said Dr. Adam Collins, a nutrition researcher.
"Withdrawal of this medication leads to hunger is uncontrolled, making excessive eating much more probable."
A Chronic Disease?
Health authorities recommend the jabs for individuals with weight-linked medical conditions, alongside recommended diet and exercise modifications.
A number of clinicians contend that, due to the likelihood of weight regain, the treatment is often life-long.
This opinion is supported by pharmaceutical companies, who note that the results "emphasize the persistent nature of obesity," similar to managing diseases like hypertension.
User Testimonies
Individuals who have stopped the jabs explain a powerful resurgence of cravings.
"It was like a trigger that goes on and you're instantly starving," described a patient.
This challenge is exacerbated if patients have not developed lasting lifestyle or habit changes during treatment.
Significant Adoption
Recent estimates suggest that millions of adults in the UK have used weight-loss jabs in the last 12 months, with interest remaining high.
- Use is greater among females than men.
- The 40s and 50s demographic shows the greatest usage rates.
- Many access the drugs through private prescriptions rather than the NHS.
Finally, clinicians emphasize that while these medications are potent tools for shedding pounds, they are not a magic solution and lasting health benefits hinges on ongoing behavioural support.
